First Distribution Agreement Executed with Sonic Healthcare

Microba and Sonic Healthcare have now signed a commercial agreement to deliver Microba’s advanced infectious disease testing technology MetaPanel™ into Australia



This new metagenomic diagnostic test has been designed to identify a comprehensive panel of pathogenic microorganisms and genes to advance the standard of care in gastrointestinal infectious disease pathology



This is the first executed agreement between Microba and Sonic Healthcare (ASX: SHL) since Sonic Healthcare acquired a 19.99% equity holding in Microba and marks the first stage of the parties delivering Microba’s world leading microbiome testing technology into Sonic Healthcare’s major markets.



A video presentation of this announcement by Microba CEO Dr Luke Reid can be viewed here https://ir.microba.com/presentations/

Related Keywords

New Zealand ,United States ,Belgium ,Switzerland ,Brisbane ,Queensland ,Australia ,United Kingdom ,Germany ,Australian ,America ,Microba Metapanel ,Douglass Hanley Moir ,Paul Griffin ,Luke Reid ,Douglass Hanly Moir Pathology Pty Ltd ,Microba Life Sciences Limited ,Sonic Healthcare Limited ,Metapanel Technology ,Microba Life Sciences ,First Distribution Agreement Executed ,Sonic Healthcare ,Life Sciences Limited ,Distribution Agreement ,Sonic Healthcare Australia Pathology ,Chief Executive Officer ,Sonic Healthcare Douglass Hanley Moir ,Professor Paul Griffin ,Infectious Diseases ,Mater Hospital ,Life Sciences ,Australian Organ Transplant ,Business Wire ,Markets ,